Vanguard Group’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Buy |
|
|||||
|
2025
Q1 | $2.01M | Sell |
|
|||||
|
2024
Q4 | $1.24M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $33K | Hold |
|
|||||
|
2024
Q1 | $30.8K | Hold |
|
|||||
|
2023
Q4 | $15.4K | Sell |
|
|||||
|
2023
Q3 | $54.3K | Sell |
|
|||||
|
2023
Q2 | $84.8K | Sell |
|
|||||
|
2023
Q1 | $139K | Hold |
|
|||||
|
2022
Q4 | $237K | Buy |
|
|||||
|
2022
Q3 | $152K | Hold |
|
|||||
|
2022
Q2 | $230K | Hold |
|
|||||
|
2022
Q1 | $255K | Hold |
|
|||||
|
2021
Q4 | $321K | Hold |
|
|||||
|
2021
Q3 | $487K | Buy |
|
|||||
|
2021
Q2 | $574K | Buy |
|
|||||
|
2021
Q1 | $279K | Buy |
|